Search
CSV
RISRemoval of vanadium by combining desferrioxamine and deferiprone chelators in rats
This study was designed to test the chelation potency of DFO and L1 while given
to animals solely or in combination after vanadium loading. Testing was performed
by using an acute experimental model on rats ...
Effect of Exjade, Exjade+DFO and Exjade+L1 Ligands on serum Iron and Aluminum uptake in rats
An investigation was conducted to evaluate the ability of two chelators, deferasirox and desferrioxamine/Deferiprone in removing Aluminum from biological system....
Chelation of Lead by combined therapy in rats
The present research aimed to characterize the potential efficiency of some chelators after Lead administration for 60 days following two dose levels of Lead to male rats.
Removal of cadmium by combining deferasirox and desferrioxamine chelators in rats
An investigation was conducted to evaluate the ability of two chelators, deferasirox and desferrioxamine
(DFO), in removing cadmium from biological system. The potential efficiency of those chelators were
investigated after cadmium...
Chelation of thallium by combining deferasirox and desferrioxamine in rats
Abstract
The hypothesis that two known chelators deferasirox (4-[3,5-bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]-benzoic acid) and desferrioxamine (DFO) might be more efficient as combined treatment than as monotherapies in removing thallium...
Chemically primed bone‐ marrow derived mesenchymal stem cells show enhanced expression of chemokine receptors contributed to their migration capability
of chemokine receptors by different
hypoxia‐mimicking agents such as valproic acid (VPA), CoCl2, and desferrioxamine (DFX) are
described. Results show DFX efficiently up‐regulate the CXCR7 and CXCR4 gene expression while VPA
increase only...